Ro Tirzepatide / Zepbound Alternative
Ro relies on commercial insurance coverage for branded Zepbound ($1,000+/mo cash). Telehealth FX provides 503A compounded Tirzepatide for $99 for your first month (then from $214–$299/mo with Affirm financing) flat rate. Prescribed through SkinnyRx with $0 clinician fees and Affirm pay-over-time options.
Head-to-Head Service & Pricing Comparison
VERIFIED 2026 RATES| Dimension / Feature | Ro (Zepbound) | Telehealth FX Partner |
|---|---|---|
| First Month Cost | $1,050/mo + $99 fee | $99/mo (1st mo promo) |
| Payment Options | Upfront full charge only | Pay over time with Affirm |
| Platform / Membership Dues | $79 - $129 / month extra | $0 — No Membership Fees |
| Clinical Oversight & Prescribing | Billed per visit or restricted messaging | Licensed US Physician ($0 Fee) |
| Dose Continuation Policy | Often forces titration restart | Guaranteed Dose-Match |
| Medication Fulfillment Speed | 5 to 10 business days | Free Cold-Chain Express Shipping |
Transfer Your Dose Without Restarting Titration
If you are currently taking Tirzepatide through another clinic or local pharmacy, our partner clinicians will match your established maintenance dose upon intake verification—saving you weeks of lost progress.
Why Patients Choose Telehealth FX for Tirzepatide
Traditional healthcare systems and high-overhead digital clinics frequently impose artificial barriers on patients seeking metabolic or hormone wellness. Between multi-week appointment wait times, complicated insurance prior authorization rejections, and recurring platform membership fees, patients are often forced to overpay by thousands of dollars each year.
At Telehealth FX, our care model is anchored in three clinical and economic commitments:
- Zero Hidden Subscription Fees: We do not charge monthly membership fees, subscription platform access fees, or per-message fees. Your flat-rate payment of $99/mo (1st mo promo) covers your entire medical care.
- Accredited 503A US Compounding: All compounded formulations are prepared exclusively by state-licensed 503A compounding pharmacies operating under federal oversight. Each batch undergoes rigorous testing to verify high chemical purity and sterility.
- 48-Hour Cold-Chain Fulfillment: Medications are shipped directly to your door in specialized temperature-monitored, insulated medical packaging to ensure full biological potency upon arrival.
How the Online Clinical Intake Works
- Complete the Online Medical Assessment: Answer key questions regarding your health history, current medications, weight loss or hormone goals, and prior treatment experience in under 3 minutes.
- Licensed Physician Review: A board-certified clinician licensed in your state evaluates your medical profile within 24 hours to determine clinical eligibility and prescribe your personalized protocol.
- Cold-Chain Home Delivery: Your medication and complete administration kit (including medical syringes and alcohol wipes) are dispatched via express cold shipping directly to your doorstep.
- Ongoing Physician Oversight: Message your medical provider at any time through your patient portal for dosage adjustments, progress reviews, or side effect guidance with zero additional fees.
Medical Purity, Legal Compliance & Patient Safety
Telehealth FX works exclusively with state-licensed 503A compounding pharmacies that compound patient-specific medications pursuant to valid medical prescriptions under Section 503A of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. § 353a).
Start Your Tirzepatide Protocol Today
Board-certified physician care. Licensed 503A compounding. Seamless dose matching and transparent flat-rate billing from $99/mo (1st mo promo).
Check Your Eligibility in 60 Seconds➔Disclaimer: Ozempic®, Wegovy®, Mounjaro®, and Zepbound® are registered trademarks of their respective owners (Novo Nordisk, Eli Lilly and Company). Telehealth FX is an independent telehealth platform and is not affiliated with, endorsed by, or sponsored by these trademark holders. Compounded medications are prepared by state-licensed compounding pharmacies pursuant to a patient-specific prescription and are not reviewed or approved by the FDA for safety or efficacy.